GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Noevir Holdings Co Ltd (TSE:4928) » Definitions » Tax Expense

Noevir Holdings Co (TSE:4928) Tax Expense : 円4,023 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Noevir Holdings Co Tax Expense?

Noevir Holdings Co's tax expense for the months ended in Mar. 2024 was 円1,047 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2024 was 円4,023 Mil.


Noevir Holdings Co Tax Expense Historical Data

The historical data trend for Noevir Holdings Co's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noevir Holdings Co Tax Expense Chart

Noevir Holdings Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,709.00 2,551.00 2,506.00 3,506.00 3,484.00

Noevir Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 931.00 1,086.00 -650.00 2,540.00 1,047.00

Noevir Holdings Co Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円4,023 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noevir Holdings Co  (TSE:4928) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Noevir Holdings Co Tax Expense Related Terms

Thank you for viewing the detailed overview of Noevir Holdings Co's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Noevir Holdings Co (TSE:4928) Business Description

Traded in Other Exchanges
N/A
Address
6-13-1 Minatojimanakamachi, Chuo-ku, Kobe, JPN, 650-8521
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses, cosmetics, and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces and sells a broad range of products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in a number of countries across the world, and focuses on developing Asian markets.

Noevir Holdings Co (TSE:4928) Headlines

No Headlines